On Monday, Mersana Therapeutics Inc (NASDAQ: MRSN) was -13.68% drop from the session before settling in for the closing price of $0.72. A 52-week range for MRSN has been $0.69 – $6.28.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 15390.52% over the last five years. When this article was written, the company’s average yearly earnings per share was at 59.40%. With a float of $86.56 million, this company’s outstanding shares have now reached $122.87 million.
The firm has a total of 123 workers. Let’s measure their productivity. In terms of profitability, gross margin is 48.0%, operating margin of -228.07%, and the pretax margin is -212.99%.
Mersana Therapeutics Inc (MRSN) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Mersana Therapeutics Inc stocks. The insider ownership of Mersana Therapeutics Inc is 29.93%, while institutional ownership is 59.60%. The most recent insider transaction that took place on Oct 28 ’24, was worth 3,580. In this transaction SVP, Chief Development Officer of this company sold 1,884 shares at a rate of $1.90, taking the stock ownership to the 54,731 shares. Before that another transaction happened on Oct 28 ’24, when Company’s Officer proposed sale 1,884 for $2.04, making the entire transaction worth $3,843.
Mersana Therapeutics Inc (MRSN) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 59.40% per share during the next fiscal year.
Mersana Therapeutics Inc (NASDAQ: MRSN) Trading Performance Indicators
You can see what Mersana Therapeutics Inc (MRSN) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.35. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.20.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.61, a number that is poised to hit -0.15 in the next quarter and is forecasted to reach -0.66 in one year’s time.
Technical Analysis of Mersana Therapeutics Inc (MRSN)
Analysing the last 5-days average volume posted by the [Mersana Therapeutics Inc, MRSN], we can find that recorded value of 17.11 million was better than the volume posted last year of 12.82 million. As of the previous 9 days, the stock’s Stochastic %D was 7.39%. Additionally, its Average True Range was 0.22.
During the past 100 days, Mersana Therapeutics Inc’s (MRSN) raw stochastic average was set at 0.96%, which indicates a significant decrease from 1.97% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 240.93% in the past 14 days, which was higher than the 140.28% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.9654, while its 200-day Moving Average is $2.2233. Now, the first resistance to watch is $0.7129. This is followed by the second major resistance level at $0.8042. The third major resistance level sits at $0.8606. If the price goes on to break the first support level at $0.5652, it is likely to go to the next support level at $0.5088. Should the price break the second support level, the third support level stands at $0.4175.
Mersana Therapeutics Inc (NASDAQ: MRSN) Key Stats
There are 123,533K outstanding shares of the company, which has a market capitalization of 76.78 million. As of now, sales total 36,860 K while income totals -171,670 K. Its latest quarter income was 12,600 K while its last quarter net income were -11,500 K.
